img
Welcome to Biotechgate, your AI-guided life sciences intelligence platform.
Company Profile Preview
Company logo

Vanda Pharmaceuticals Inc.

Headquarters
Washington, USA
See full record
Company
Therapeutics
Technologies
Clinical trials
License agreements
Financing rounds
Management
Partnering Interests
Financials
Reports & Forecasts

Main Sector

Biotechnology - Therapeutics and Diagnostics

Subsectors

Other
Antibodies
Anti-infectives
Nucleic acid drugs
Small molecules

Indications

Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Social circumstances / substance related disorders / addiction

Products

In development: 22
On the market: 4

Description

Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The company's product BYSANTI™ (milsaperidone) is a prescription medication used for the treatment of schizophrenia and the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.. The company's another product Fanapt® (iloperidone) is a prescription medication...

 

Log in to see full record »

No account yet?

Try Biotechgate now - learn about subscription plans and pricing!
Learn more Request a demo
© 2026 Venture Valuation
Terms of Use & Privacy Policy